Pfizer Launches Expanded Access Program For CCR5 Antagonist Maraviroc
Pfizer will begin enrolling HIV patients in the next “few months” and will recruit investigators that have not previously worked in expanded access.
Pfizer will begin enrolling HIV patients in the next “few months” and will recruit investigators that have not previously worked in expanded access.